Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1127698

	registered interest
	date	20/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 April 2018 to Question 135010 on Sickle Cell Diseases, if he will provide updated estimates of the costs to the NHS of treating sickle cell anaemia in (a) England (b) each NHS England region and (c) each Clinical Commissioning Group area in each year since 2009-10.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256313
	answer	answer is ministerial correction date of answer 23/05/2019 answer text <p>NHS England specialised commissioning only reports the costs of the National Health Service specialised commissioning services by region and hub for treating sickle cell disease, which includes sickle cell anaemia. This information is shown in the following table. The data is not broken down by clinical commissioning group (CCG) area. This information does not include non-specialised activity that CCGs may fund. Information was not collected prior to 2015/16 and information for 2018/19 is not currently available.</p><p> </p><p>Costs of NHS specialised commissioning services by region and hub for treating sickle cell disease</p><table><tbody><tr><td><p>Region</p></td><td><p>Hub</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>£ million</p></td><td><p>£ million</p></td><td><p>£ million</p></td></tr><tr><td><p>London</p></td><td><p> </p></td><td><p>29.9</p></td><td><p>31.0</p></td><td><p>44.8</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Midlands and East</p></td><td><p>East of England</p></td><td><p>1.6</p></td><td><p>1.7</p></td><td><p>3.3</p></td></tr><tr><td><p> </p></td><td><p>East Midlands</p></td><td><p>0.8</p></td><td><p>0.8</p></td><td><p>1.4</p></td></tr><tr><td><p> </p></td><td><p>West Midlands</p></td><td><p>2.7</p></td><td><p>2.5</p></td><td><p>3.2</p></td></tr><tr><td><p>Midlands and East Total</p></td><td><p> </p></td><td><p>5.1</p></td><td><p>5.0</p></td><td><p>7.9</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>North</p></td><td><p>North East</p></td><td><p>0.1</p></td><td><p>0.2</p></td><td><p>0.2</p></td></tr><tr><td><p> </p></td><td><p>North West</p></td><td><p>2.8</p></td><td><p>2.3</p></td><td><p>2.3</p></td></tr><tr><td><p> </p></td><td><p>Yorkshire &amp; Humber</p></td><td><p>1.1</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>North Total</p></td><td><p> </p></td><td><p>4.0</p></td><td><p>3.0</p></td><td><p>3.4</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>South</p></td><td><p>South East</p></td><td><p>1.8</p></td><td><p>1.9</p></td><td><p>2.6</p></td></tr><tr><td><p> </p></td><td><p>South West</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.7</p></td></tr><tr><td><p> </p></td><td><p>Wessex</p></td><td><p>0.5</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>South Total</p></td><td><p> </p></td><td><p>2.5</p></td><td><p>2.5</p></td><td><p>4.2</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>41.6</p></td><td><p>41.5</p></td><td><p>60.4</p></td></tr></tbody></table><p> </p><p>Source: Costs extracted from the annual CCG exercise.</p><p>Between 2012/13 and 2018/19, approximately 117,000 patients were admitted to hospital with a primary diagnosis of sickle cell disease. Information for years prior to 2012/13 is not available. NHS England has advised that it is unable to separate expenditure between admitted patient care episodes and the overall costs provided in the table without incurring disproportionate cost.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256314 question first answered 23/05/2019 14:40:15 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1127699

	registered interest
	date	20/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 8 December 2014 to Question 216527 on Sickle Cell Diseases, if he will provide updated estimates of the costs to NHS of admitted patient care episodes for sickle cell anaemia in (a) England, (b) each NHS England region and (c) each Clinical Commissioning Group area in each year since 2009-10.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256314
	answer	answer is ministerial correction date of answer 23/05/2019 answer text <p>NHS England specialised commissioning only reports the costs of the National Health Service specialised commissioning services by region and hub for treating sickle cell disease, which includes sickle cell anaemia. This information is shown in the following table. The data is not broken down by clinical commissioning group (CCG) area. This information does not include non-specialised activity that CCGs may fund. Information was not collected prior to 2015/16 and information for 2018/19 is not currently available.</p><p> </p><p>Costs of NHS specialised commissioning services by region and hub for treating sickle cell disease</p><table><tbody><tr><td><p>Region</p></td><td><p>Hub</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>£ million</p></td><td><p>£ million</p></td><td><p>£ million</p></td></tr><tr><td><p>London</p></td><td><p> </p></td><td><p>29.9</p></td><td><p>31.0</p></td><td><p>44.8</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Midlands and East</p></td><td><p>East of England</p></td><td><p>1.6</p></td><td><p>1.7</p></td><td><p>3.3</p></td></tr><tr><td><p> </p></td><td><p>East Midlands</p></td><td><p>0.8</p></td><td><p>0.8</p></td><td><p>1.4</p></td></tr><tr><td><p> </p></td><td><p>West Midlands</p></td><td><p>2.7</p></td><td><p>2.5</p></td><td><p>3.2</p></td></tr><tr><td><p>Midlands and East Total</p></td><td><p> </p></td><td><p>5.1</p></td><td><p>5.0</p></td><td><p>7.9</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>North</p></td><td><p>North East</p></td><td><p>0.1</p></td><td><p>0.2</p></td><td><p>0.2</p></td></tr><tr><td><p> </p></td><td><p>North West</p></td><td><p>2.8</p></td><td><p>2.3</p></td><td><p>2.3</p></td></tr><tr><td><p> </p></td><td><p>Yorkshire &amp; Humber</p></td><td><p>1.1</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>North Total</p></td><td><p> </p></td><td><p>4.0</p></td><td><p>3.0</p></td><td><p>3.4</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>South</p></td><td><p>South East</p></td><td><p>1.8</p></td><td><p>1.9</p></td><td><p>2.6</p></td></tr><tr><td><p> </p></td><td><p>South West</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.7</p></td></tr><tr><td><p> </p></td><td><p>Wessex</p></td><td><p>0.5</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>South Total</p></td><td><p> </p></td><td><p>2.5</p></td><td><p>2.5</p></td><td><p>4.2</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>41.6</p></td><td><p>41.5</p></td><td><p>60.4</p></td></tr></tbody></table><p> </p><p>Source: Costs extracted from the annual CCG exercise.</p><p>Between 2012/13 and 2018/19, approximately 117,000 patients were admitted to hospital with a primary diagnosis of sickle cell disease. Information for years prior to 2012/13 is not available. NHS England has advised that it is unable to separate expenditure between admitted patient care episodes and the overall costs provided in the table without incurring disproportionate cost.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256313 question first answered 23/05/2019 14:40:15 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson